Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Edward Tenthoff's Stock Ratings
Piper Sandler Analyst
Edward Tenthoff is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
3.32%
Smart Score
Overall Average Return Percentile
41st
Number of Ratings
267
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/10/2025 | CAPR | Buy Now | Capricor Therapeutics | $26.59 | 69.27% | $20 → $45 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $86.12 | 45.15% | $98 → $125 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/08/2025 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | 76.45% | $16 → $23 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/21/2025 | MRNA | Buy Now | Moderna | $29.27 | 115.27% | $69 → $63 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/19/2025 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -0.13% | $45 → $70 | Maintains | Overweight | Get Alert | |
| 11/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.19 | 174.09% | $5 → $6 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/31/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | 22.9% | $449 → $489 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/30/2025 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | 22.75% | $12.5 → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/09/2025 | KPTI | Buy Now | Karyopharm Therapeutics | $6.88 | 74.42% | $15 → $12 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/15/2025 | CAMP | Buy Now | Camp4 Therapeutics | $6.43 | 86.48% | $18 → $12 | Maintains | Overweight | Get Alert | |
| 08/01/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | 12.85% | $304 → $449 | Maintains | Overweight | Get Alert | |
| 07/15/2025 | NXTC | Buy Now | NextCure | $11.73 | 27.88% | $36 → $15 | Maintains | Overweight | Get Alert | |
| 07/09/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.19 | 128.4% | → $5 | Initiates | → Overweight | Get Alert | |
| 06/27/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | 83.53% | $105 → $105 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/16/2025 | STRO | Buy Now | Sutro Biopharma | $9.76 | -79.51% | $2 → $2 | Upgrade | Neutral → Overweight | Get Alert | |
| 06/03/2025 | BMEA | Buy Now | Biomea Fusion | $1.35 | 416.61% | → $7 | Assumes | → Overweight | Get Alert | |
| 05/29/2025 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | -30.96% | $6 → $9 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ITOS | Buy Now | ITeos Therapeutics | — | — | $16 → $12 | Maintains | Overweight | Get Alert | |
| 05/02/2025 | ARVN | Buy Now | Arvinas | $12.46 | 12.31% | $24 → $14 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/20/2025 | IPSC | Buy Now | Century Therapeutics | $0.58 | 245.78% | $4 → $2 | Maintains | Overweight | Get Alert | |
| 02/28/2025 | DYN | Buy Now | Dyne Therapeutics | $19.77 | 142.79% | $53 → $48 | Maintains | Overweight | Get Alert | |
| 02/07/2025 | MESO | Buy Now | Mesoblast | $17.82 | 34.68% | $15 → $24 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/30/2024 | LEGN | Buy Now | Legend Biotech | $22.33 | 249.31% | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/30/2024 | IPSC | Buy Now | Century Therapeutics | $0.58 | 591.56% | $12 → $4 | Maintains | Overweight | Get Alert | |
| 12/19/2024 | MESO | Buy Now | Mesoblast | $17.82 | -15.82% | $11 → $15 | Maintains | Overweight | Get Alert | |
| 12/02/2024 | XNCR | Buy Now | Xencor | $16.70 | 79.64% | $20 → $30 | Upgrade | Neutral → Overweight | Get Alert | |
| 11/27/2024 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -35.8% | $62 → $45 | Maintains | Overweight | Get Alert | |
| 11/18/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -25.61% | $296 → $296 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/18/2024 | MRNA | Buy Now | Moderna | $29.27 | 135.78% | $115 → $69 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/15/2024 | OMGA | Buy Now | Omega Therapeutics | — | — | $9 → $4 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | KRON | Buy Now | Kronos Bio | — | — | $6 → $1 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/13/2024 | TPST | Buy Now | Tempest Therapeutics | $2.92 | 71.49% | $8 → $5 | Maintains | Overweight | Get Alert | |
| 11/05/2024 | CAMP | Buy Now | Camp4 Therapeutics | $6.43 | 179.72% | → $18 | Initiates | → Overweight | Get Alert | |
| 10/21/2024 | CAPR | Buy Now | Capricor Therapeutics | $26.59 | 31.65% | → $35 | Initiates | → Overweight | Get Alert | |
| 10/11/2024 | STRO | Buy Now | Sutro Biopharma | $9.76 | 12.7% | $11 → $11 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/08/2024 | KRON | Buy Now | Kronos Bio | — | — | $6 → $6 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/08/2024 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -11.54% | $62 → $62 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/23/2024 | DYN | Buy Now | Dyne Therapeutics | $19.77 | 168.08% | $53 → $53 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/20/2024 | SKYE | Buy Now | Skye Bioscience | $1.08 | 1751.85% | $20 → $20 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/17/2024 | OPK | Buy Now | OPKO Health | $1.37 | 118.98% | $3 → $3 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/13/2024 | MRNA | Buy Now | Moderna | $29.27 | 292.96% | $157 → $115 | Maintains | Overweight | Get Alert | |
| 08/13/2024 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 999900% | $13 → $5 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/13/2024 | DYN | Buy Now | Dyne Therapeutics | $19.77 | 168.08% | $43 → $53 | Maintains | Overweight | Get Alert | |
| 08/02/2024 | MRNA | Buy Now | Moderna | $29.27 | 436.48% | $214 → $157 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/26/2024 | CUE | Buy Now | Cue Biopharma | $0.49 | 508.52% | $8 → $3 | Maintains | Overweight | Get Alert | |
| 07/23/2024 | MESO | Buy Now | Mesoblast | $17.82 | -38.27% | $4 → $11 | Upgrade | Neutral → Overweight | Get Alert | |
| 07/18/2024 | OPK | Buy Now | OPKO Health | $1.37 | 118.98% | $5 → $3 | Maintains | Overweight | Get Alert | |
| 06/28/2024 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.58 | -3.5% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/27/2024 | MRNA | Buy Now | Moderna | $29.27 | 631.25% | $214 → $214 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/21/2024 | TPST | Buy Now | Tempest Therapeutics | $2.92 | 174.39% | $8 → $8 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/17/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | 83.53% | $105 → $105 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/17/2024 | LEGN | Buy Now | Legend Biotech | $22.33 | 303.05% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/17/2024 | IPSC | Buy Now | Century Therapeutics | $0.58 | 1974.69% | $9 → $12 | Maintains | Overweight | Get Alert | |
| 06/17/2024 | FATE | Buy Now | Fate Therapeutics | $1.11 | 439.71% | $4 → $6 | Upgrade | Neutral → Overweight | Get Alert | |
| 05/10/2024 | FATE | Buy Now | Fate Therapeutics | $1.11 | 259.81% | $7 → $4 | Maintains | Neutral | Get Alert | |
| 04/12/2024 | IPSC | Buy Now | Century Therapeutics | $0.58 | 1456.02% | $10 → $9 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/03/2024 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 2599900% | → $13 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/03/2024 | CUE | Buy Now | Cue Biopharma | $0.49 | 1522.72% | $8 → $8 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/03/2024 | APTO | Buy Now | Aptose Biosciences | — | — | $5 → $5 | Maintains | Overweight | Get Alert | |
| 04/03/2024 | STRO | Buy Now | Sutro Biopharma | $9.76 | 12.7% | $12 → $11 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/03/2024 | OMGA | Buy Now | Omega Therapeutics | — | — | $10 → $9 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/01/2024 | OPK | Buy Now | OPKO Health | $1.37 | 264.96% | → $5 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/14/2024 | SKYE | Buy Now | Skye Bioscience | $1.08 | 1751.85% | $12 → $20 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/13/2024 | ASLN | Buy Now | ASLAN Pharma | — | — | $15 → $10 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/11/2024 | ASLN | Buy Now | ASLAN Pharma | — | — | $15 → $15 | Maintains | Overweight | Get Alert | |
| 03/06/2024 | DYN | Buy Now | Dyne Therapeutics | $19.77 | 46.69% | $27 → $29 | Maintains | Overweight | Get Alert | |
| 03/05/2024 | MIST | Buy Now | Milestone Pharmaceuticals | $2.48 | 101.64% | $6 → $5 | Maintains | Overweight | Get Alert | |
| 02/28/2024 | XNCR | Buy Now | Xencor | $16.70 | 43.71% | $37 → $24 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/28/2024 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | 15.07% | $13 → $15 | Maintains | Overweight | Get Alert | |
| 02/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $86.12 | -34.97% | $39 → $56 | Maintains | Overweight | Get Alert | |
| 02/05/2024 | SKYE | Buy Now | Skye Bioscience | $1.08 | 1011.11% | → $12 | Initiates | → Overweight | Get Alert | |
| 02/01/2024 | APTO | Buy Now | Aptose Biosciences | — | — | $12 → $5 | Maintains | Overweight | Get Alert | |
| 12/19/2023 | KRON | Buy Now | Kronos Bio | — | — | $7 → $6 | Maintains | Overweight | Get Alert | |
| 12/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -45.46% | $210 → $217 | Maintains | Overweight | Get Alert | |
| 12/11/2023 | PSTX | Buy Now | Poseida Therapeutics | — | — | $8 → $10 | Maintains | Overweight | Get Alert | |
| 11/15/2023 | STRO | Buy Now | Sutro Biopharma | $9.76 | 22.95% | $18 → $12 | Maintains | Overweight | Get Alert | |
| 11/15/2023 | GMDA | Buy Now | Gamida Cell | — | — | $5 → $2 | Maintains | Overweight | Get Alert | |
| 11/06/2023 | CUE | Buy Now | Cue Biopharma | $0.49 | 1522.72% | $7 → $8 | Maintains | Overweight | Get Alert | |
| 11/03/2023 | KYMR | Buy Now | Kymera Therapeutics | $86.12 | -55.87% | $58 → $38 | Maintains | Overweight | Get Alert | |
| 10/24/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | → $12.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/23/2023 | ARVN | Buy Now | Arvinas | $12.46 | 341.24% | $70 → $55 | Maintains | Overweight | Get Alert | |
| 10/03/2023 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 1399900% | $11 → $7 | Maintains | Overweight | Get Alert | |
| 09/28/2023 | GRTS | Buy Now | Gritstone Bio | — | — | $6 → $7 | Maintains | Overweight | Get Alert | |
| 08/14/2023 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | -13.18% | $28 → $31 | Maintains | Overweight | Get Alert | |
| 08/11/2023 | APTO | Buy Now | Aptose Biosciences | — | — | $37 → $12 | Maintains | Overweight | Get Alert | |
| 08/10/2023 | IPSC | Buy Now | Century Therapeutics | $0.58 | 1628.91% | $14 → $10 | Maintains | Overweight | Get Alert | |
| 08/10/2023 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 1692.11% | $6 → $0.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/04/2023 | MESO | Buy Now | Mesoblast | $17.82 | -88.78% | $7 → $2 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/21/2023 | LIFE | Buy Now | aTyr Pharma | — | — | $13 → $20 | Maintains | Overweight | Get Alert | |
| 06/07/2023 | APTO | Buy Now | Aptose Biosciences | — | — | $45 → $37 | Maintains | Overweight | Get Alert | |
| 06/02/2023 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -15.82% | $52 → $59 | Maintains | Overweight | Get Alert | |
| 04/11/2023 | LIFE | Buy Now | aTyr Pharma | — | — | $9 → $13 | Maintains | Overweight | Get Alert | |
| 03/23/2023 | TPST | Buy Now | Tempest Therapeutics | $2.92 | 105.79% | $10 → $6 | Maintains | Overweight | Get Alert | |
| 03/03/2023 | OMGA | Buy Now | Omega Therapeutics | — | — | $8 → $10 | Maintains | Overweight | Get Alert | |
| 02/27/2023 | ASLN | Buy Now | ASLAN Pharma | — | — | $4 → $3 | Maintains | Overweight | Get Alert | |
| 02/24/2023 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 02/21/2023 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 21405.38% | → $6 | Initiates | → Overweight | Get Alert | |
| 02/07/2023 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -25.81% | $55 → $52 | Maintains | Overweight | Get Alert | |
| 01/23/2023 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | 61.1% | $18 → $21 | Maintains | Overweight | Get Alert | |
| 01/10/2023 | STRO | Buy Now | Sutro Biopharma | $9.76 | 84.43% | $16 → $18 | Maintains | Overweight | Get Alert | |
| 01/06/2023 | IPSC | Buy Now | Century Therapeutics | $0.58 | 2320.47% | $24 → $14 | Maintains | Overweight | Get Alert | |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.11 | 979.43% | $71 → $12 | Downgrade | Overweight → Neutral | Get Alert | |
| 01/05/2023 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 3999900% | $27 → $20 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | JNCE | Buy Now | Jounce Therapeutics | — | — | $6 → $5 | Maintains | Overweight | Get Alert | |
| 12/20/2022 | MRNA | Buy Now | Moderna | $29.27 | 641.5% | $214 → $217 | Maintains | Overweight | Get Alert | |
| 12/20/2022 | LEGN | Buy Now | Legend Biotech | $22.33 | 249.31% | $72 → $78 | Maintains | Overweight | Get Alert | |
| 12/16/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -36.41% | $226 → $253 | Maintains | Overweight | Get Alert | |
| 12/12/2022 | XFOR | Buy Now | X4 Pharmaceuticals | $3.91 | -23.27% | → $3 | Initiates | → Overweight | Get Alert | |
| 11/23/2022 | ARVN | Buy Now | Arvinas | $12.46 | 549.82% | $76 → $81 | Maintains | Overweight | Get Alert | |
| 11/21/2022 | CUE | Buy Now | Cue Biopharma | $0.49 | 1319.88% | → $7 | Initiates | → Overweight | Get Alert | |
| 11/14/2022 | ARAV | Buy Now | Aravive | — | — | $6 → $2 | Maintains | Overweight | Get Alert | |
| 11/11/2022 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | -4.78% | $30 → $34 | Maintains | Overweight | Get Alert | |
| 11/10/2022 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -8.69% | $72 → $64 | Maintains | Overweight | Get Alert | |
| 11/09/2022 | KRON | Buy Now | Kronos Bio | — | — | $13 → $7 | Maintains | Overweight | Get Alert | |
| 11/04/2022 | NXTC | Buy Now | NextCure | $11.73 | -48.85% | $13 → $6 | Maintains | Overweight | Get Alert | |
| 10/31/2022 | GRTS | Buy Now | Gritstone Bio | — | — | → $6 | Initiates | → Overweight | Get Alert | |
| 09/16/2022 | ASLN | Buy Now | ASLAN Pharma | — | — | $3 → $4 | Maintains | Overweight | Get Alert | |
| 09/07/2022 | MCRB | Buy Now | Seres Therapeutics | $16.01 | -43.79% | $7 → $9 | Maintains | Overweight | Get Alert | |
| 09/06/2022 | MESO | Buy Now | Mesoblast | $17.82 | -60.72% | → $7 | Initiates | → Overweight | Get Alert | |
| 08/25/2022 | PRTC | Buy Now | PureTech Health | $17.34 | 153.75% | $37 → $44 | Maintains | Overweight | Get Alert | |
| 08/16/2022 | LIFE | Buy Now | aTyr Pharma | — | — | $11 → $14 | Maintains | Overweight | Get Alert | |
| 08/09/2022 | PSTX | Buy Now | Poseida Therapeutics | — | — | $9 → $11 | Maintains | Overweight | Get Alert | |
| 08/05/2022 | OPK | Buy Now | OPKO Health | $1.37 | 191.97% | $5 → $4 | Maintains | Overweight | Get Alert | |
| 06/22/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | 111.5% | $115 → $121 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | XNCR | Buy Now | Xencor | $16.70 | 151.5% | $66 → $42 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | STRO | Buy Now | Sutro Biopharma | $9.76 | 43.44% | $29 → $14 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | OMGA | Buy Now | Omega Therapeutics | — | — | $30 → $7 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | NXTC | Buy Now | NextCure | $11.73 | 10.83% | $21 → $13 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | MCRB | Buy Now | Seres Therapeutics | $16.01 | -56.28% | $32 → $7 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | KYMR | Buy Now | Kymera Therapeutics | $86.12 | -50.07% | $91 → $43 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | KRON | Buy Now | Kronos Bio | — | — | $30 → $13 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | JNCE | Buy Now | Jounce Therapeutics | — | — | $17 → $9 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $4 → $3 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | FATE | Buy Now | Fate Therapeutics | $1.11 | 6286.62% | $113 → $71 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.00 | 1499900% | $4 → $1.5 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | DYN | Buy Now | Dyne Therapeutics | $19.77 | -39.3% | $16 → $12 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | 101.01% | $180 → $115 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.46 | 395.65% | $76 → $37 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | ASLN | Buy Now | ASLAN Pharma | — | — | $8 → $3 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | ARVN | Buy Now | Arvinas | $12.46 | 509.71% | $116 → $76 | Maintains | Overweight | Get Alert | |
| 05/23/2022 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | $7 → $4 | Maintains | Overweight | Get Alert | |
| 05/18/2022 | LIFE | Buy Now | aTyr Pharma | — | — | $19 → $11 | Maintains | Overweight | Get Alert | |
| 05/18/2022 | MRNA | Buy Now | Moderna | $29.27 | 631.25% | $348 → $214 | Maintains | Overweight | Get Alert | |
| 05/17/2022 | IPSC | Buy Now | Century Therapeutics | $0.58 | 3703.6% | $38 → $22 | Maintains | Overweight | Get Alert | |
| 05/13/2022 | APVO | Buy Now | Aptevo Therapeutics | $1.08 | 1751.85% | $69 → $20 | Maintains | Overweight | Get Alert | |
| 05/13/2022 | PSTX | Buy Now | Poseida Therapeutics | — | — | $19 → $9 | Maintains | Overweight | Get Alert | |
| 05/12/2022 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | -15.98% | $52 → $30 | Maintains | Overweight | Get Alert | |
| 05/12/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.58 | 26.66% | $40 → $21 | Maintains | Overweight | Get Alert | |
| 05/11/2022 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | 2.73% | $89 → $72 | Maintains | Overweight | Get Alert | |
| 05/10/2022 | OPK | Buy Now | OPKO Health | $1.37 | 264.96% | $6 → $5 | Maintains | Overweight | Get Alert | |
| 04/22/2022 | MIST | Buy Now | Milestone Pharmaceuticals | $2.48 | 303.27% | $8 → $10 | Upgrade | Neutral → Overweight | Get Alert | |
| 03/30/2022 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $8 → $4 | Maintains | Overweight | Get Alert | |
| 03/11/2022 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | 45.64% | $61 → $52 | Maintains | Overweight | Get Alert | |
| 02/28/2022 | KRON | Buy Now | Kronos Bio | — | — | $50 → $30 | Maintains | Overweight | Get Alert | |
| 01/03/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -47.72% | $181 → $208 | Upgrade | Neutral → Overweight | Get Alert | |
| 12/21/2021 | LEGN | Buy Now | Legend Biotech | $22.33 | 195.57% | → $66 | Initiates | → Overweight | Get Alert | |
| 11/29/2021 | ARGX | Buy Now | argenx | $853.00 | -58.5% | $250 → $354 | Upgrade | Neutral → Overweight | Get Alert | |
| 10/15/2021 | MRNA | Buy Now | Moderna | $29.27 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 09/21/2021 | LIFE | Buy Now | aTyr Pharma | — | — | → $19 | Initiates | → Overweight | Get Alert | |
| 09/20/2021 | SYBX | Buy Now | Synlogic | $1.07 | 741.12% | $7 → $9 | Maintains | Overweight | Get Alert | |
| 08/24/2021 | OMGA | Buy Now | Omega Therapeutics | — | — | → $30 | Initiates | → Overweight | Get Alert | |
| 08/06/2021 | MRNA | Buy Now | Moderna | $29.27 | 1420.59% | $246 → $445 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/04/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -54.51% | → $181 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/30/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -28.65% | $261 → $323 | Maintains | Overweight | Get Alert | |
| 07/26/2021 | PNT | Buy Now | POINT Biopharma Global | — | — | → $17 | Initiates | → Overweight | Get Alert | |
| 07/19/2021 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.58 | 141.25% | → $40 | Initiates | → Overweight | Get Alert | |
| 07/13/2021 | IPSC | Buy Now | Century Therapeutics | $0.58 | 6469.85% | → $38 | Initiates | → Overweight | Get Alert | |
| 07/06/2021 | TPST | Buy Now | Tempest Therapeutics | $2.92 | 688.86% | → $23 | Initiates | → Overweight | Get Alert | |
| 06/21/2021 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | 70.84% | → $61 | Initiates | → Overweight | Get Alert | |
| 06/14/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -42.34% | $347 → $261 | Maintains | Overweight | Get Alert | |
| 05/07/2021 | CCXI | Buy Now | ChemoCentryx | — | — | $80 → $25 | Downgrade | Overweight → Neutral | Get Alert | |
| 04/15/2021 | MRNA | Buy Now | Moderna | $29.27 | 699.59% | $208 → $234 | Reiterates | → Overweight | Get Alert | |
| 03/15/2021 | MRNA | Buy Now | Moderna | $29.27 | 610.75% | → $208 | Reiterates | → Overweight | Get Alert | |
| 03/15/2021 | JNCE | Buy Now | Jounce Therapeutics | — | — | → $20 | Initiates | → Overweight | Get Alert | |
| 02/18/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | → $7 | Initiates | → Overweight | Get Alert | |
| 02/17/2021 | MRNA | Buy Now | Moderna | $29.27 | 610.75% | $170 → $208 | Maintains | Overweight | Get Alert | |
| 02/17/2021 | FATE | Buy Now | Fate Therapeutics | $1.11 | 10334.47% | $99 → $116 | Maintains | Overweight | Get Alert | |
| 02/16/2021 | EXEL | Buy Now | Exelixis | $41.47 | -13.19% | $33 → $36 | Maintains | Overweight | Get Alert | |
| 02/09/2021 | KLDO | Buy Now | Kaleido Biosciences | $0.00 | 18999900% | → $19 | Initiates | → Overweight | Get Alert | |
| 02/05/2021 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | 41.25% | $90 → $99 | Maintains | Overweight | Get Alert | |
| 02/02/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -23.35% | $307 → $347 | Maintains | Overweight | Get Alert | |
| 02/02/2021 | ARGX | Buy Now | argenx | $853.00 | -64.48% | $300 → $303 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/13/2020 | KYMR | Buy Now | Kymera Therapeutics | $86.12 | — | — | Initiates | → Overweight | Get Alert | |
| 11/11/2020 | APVO | Buy Now | Aptevo Therapeutics | $1.08 | 6288.89% | $32 → $69 | Maintains | Overweight | Get Alert | |
| 11/03/2020 | KRON | Buy Now | Kronos Bio | — | — | → $50 | Initiates | → Overweight | Get Alert | |
| 10/29/2020 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | 87.03% | $128 → $107 | Maintains | Overweight | Get Alert | |
| 10/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | $67 → $71 | Maintains | Overweight | Get Alert | |
| 10/16/2020 | FULC | Buy Now | Fulcrum Therapeutics | $13.04 | 68.78% | → $22 | Initiates | → Overweight | Get Alert | |
| 10/12/2020 | DYN | Buy Now | Dyne Therapeutics | $19.77 | 71.98% | → $34 | Initiates | → Overweight | Get Alert | |
| 09/30/2020 | ARGX | Buy Now | argenx | $853.00 | -64.83% | $258 → $300 | Maintains | Overweight | Get Alert | |
| 09/21/2020 | EXEL | Buy Now | Exelixis | $41.47 | -20.42% | $30 → $33 | Maintains | Overweight | Get Alert | |
| 08/18/2020 | MCRB | Buy Now | Seres Therapeutics | $16.01 | 149.84% | → $40 | Initiates | → Overweight | Get Alert | |
| 05/26/2020 | GMDA | Buy Now | Gamida Cell | — | — | → $13 | Initiates | → Overweight | Get Alert | |
| 05/14/2020 | RMED | Buy Now | Ra Medical Systems | — | — | $1.5 → $1 | Maintains | Neutral | Get Alert | |
| 05/12/2020 | MRKR | Buy Now | Marker Therapeutics | $1.38 | 81.16% | $5 → $2.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/04/2020 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | — | Initiates | → Overweight | Get Alert | |
| 04/01/2020 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | $20 → $18.5 | Reiterates | → Overweight | Get Alert | |
| 03/24/2020 | MIST | Buy Now | Milestone Pharmaceuticals | $2.48 | 20.98% | → $3 | Downgrade | Overweight → Neutral | Get Alert | |
| 01/27/2020 | MTNB | Buy Now | Matinas BioPharma Hldgs | $0.76 | 294.74% | → $3 | Initiates | → Overweight | Get Alert | |
| 01/06/2020 | ARVN | Buy Now | Arvinas | $12.46 | 365.3% | $35 → $58 | Maintains | Overweight | Get Alert | |
| 01/06/2020 | ARGX | Buy Now | argenx | $853.00 | -77.26% | $177 → $194 | Maintains | Overweight | Get Alert | |
| 01/06/2020 | IGMS | Buy Now | IGM Biosciences | — | — | $26 → $53 | Maintains | Overweight | Get Alert | |
| 01/06/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -37.26% | $247 → $284 | Maintains | Overweight | Get Alert | |
| 12/27/2019 | SBPH | Buy Now | Spring Bank | — | — | $10 → $1.7 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/25/2019 | OPK | Buy Now | OPKO Health | $1.37 | 82.48% | → $2.5 | Initiates | → Overweight | Get Alert | |
| 11/13/2019 | MRKR | Buy Now | Marker Therapeutics | $1.38 | 334.78% | $10 → $6 | Maintains | Overweight | Get Alert | |
| 11/13/2019 | ARVN | Buy Now | Arvinas | $12.46 | 180.79% | $32 → $35 | Maintains | Overweight | Get Alert | |
| 10/31/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -45.44% | $230 → $247 | Maintains | Overweight | Get Alert | |
| 10/14/2019 | IGMS | Buy Now | IGM Biosciences | — | — | → $26 | Initiates | → Overweight | Get Alert | |
| 09/16/2019 | FATE | Buy Now | Fate Therapeutics | $1.11 | 2418.67% | $30 → $28 | Maintains | Overweight | Get Alert | |
| 09/05/2019 | NXTC | Buy Now | NextCure | $11.73 | 360.36% | $26 → $54 | Maintains | Overweight | Get Alert | |
| 09/03/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -63.56% | $142 → $145 | Maintains | Overweight | Get Alert | |
| 08/13/2019 | RMED | Buy Now | Ra Medical Systems | — | — | $9 → $1.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/01/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $452.69 | -49.19% | $217 → $230 | Maintains | Overweight | Get Alert | |
| 06/17/2019 | BCYC | Buy Now | Bicycle Therapeutics | $7.46 | 167.92% | → $20 | Initiates | → Overweight | Get Alert | |
| 06/03/2019 | NXTC | Buy Now | NextCure | $11.73 | 121.65% | → $26 | Initiates | → Overweight | Get Alert | |
| 06/03/2019 | MIST | Buy Now | Milestone Pharmaceuticals | $2.48 | 968.68% | → $26.5 | Initiates | → Overweight | Get Alert | |
| 02/11/2019 | CCXI | Buy Now | ChemoCentryx | — | — | → $20 | Initiates | → Overweight | Get Alert | |
| 01/02/2019 | MRNA | Buy Now | Moderna | $29.27 | -17.99% | → $24 | Initiates | → Overweight | Get Alert | |
| 10/29/2018 | PTI | Buy Now | Proteostasis Therapeutics | — | — | → $14 | Initiates | → Overweight | Get Alert | |
| 10/22/2018 | RMED | Buy Now | Ra Medical Systems | — | — | → $23 | Initiates | → Overweight | Get Alert | |
| 10/22/2018 | STRO | Buy Now | Sutro Biopharma | $9.76 | 135.66% | → $23 | Initiates | → Overweight | Get Alert | |
| 10/22/2018 | ARVN | Buy Now | Arvinas | $12.46 | 84.52% | → $23 | Initiates | → Overweight | Get Alert | |
| 09/18/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | $52 → $75 | Upgrade | Neutral → Overweight | Get Alert | |
| 07/10/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 05/01/2018 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.00 | 19999900% | → $20 | Initiates | → Overweight | Get Alert | |
| 01/29/2018 | SYBX | Buy Now | Synlogic | $1.07 | 1395.33% | → $16 | Initiates | → Overweight | Get Alert | |
| 12/22/2017 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | — | — | Assumes | → Overweight | Get Alert | |
| 12/18/2017 | FATE | Buy Now | Fate Therapeutics | $1.11 | 799.52% | → $10 | Initiates | → Overweight | Get Alert | |
| 12/11/2017 | ASNS | Buy Now | Actelis Networks | $1.58 | 1355.7% | → $23 | Initiates | → Overweight | Get Alert | |
| 11/27/2017 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 10/31/2017 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 5999900% | → $30 | Assumes | Overweight → Overweight | Get Alert | |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 08/28/2017 | TTPH | Buy Now | Tetraphase Pharmaceutical | — | — | → $14 | Initiates | → Overweight | Get Alert | |
| 04/17/2017 | OMED | Buy Now | OptMed, Inc. | — | — | $17 → $5 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/13/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 11/30/2016 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 11/14/2016 | CRSP | Buy Now | CRISPR Therapeutics | $57.21 | -63.29% | → $21 | Initiates | → Overweight | Get Alert | |
| 10/04/2016 | XNCR | Buy Now | Xencor | $16.70 | — | — | Initiates | → Overweight | Get Alert | |
| 10/04/2016 | VSAR | Buy Now | Versartis | — | — | — | Initiates | → Overweight | Get Alert | |
| 09/09/2016 | APVO | Buy Now | Aptevo Therapeutics | $1.08 | 548.15% | → $7 | Initiates | → Overweight | Get Alert | |
| 07/25/2016 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | — | — | Initiates | → Overweight | Get Alert | |
| 05/19/2016 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | — | Initiates | → Overweight | Get Alert | |
| 09/25/2015 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -71.47% | $12 → $20 | Maintains | Overweight | Get Alert | |
| 06/15/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -54.76% | $150 → $180 | Maintains | Outperform | Get Alert | |
| 02/10/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 11/27/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -50.17% | → $376 | Initiates | → Overweight | Get Alert | |
| 11/05/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -50.17% | $360 → $376 | Maintains | Overweight | Get Alert | |
| 10/21/2013 | ARWR | Buy Now | Arrowhead Pharma | $70.09 | -82.88% | → $12 | Initiates | → Overweight | Get Alert | |
| 09/30/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -52.29% | $336 → $360 | Maintains | Overweight | Get Alert | |
| 08/12/2013 | OMED | Buy Now | OptMed, Inc. | — | — | → $30 | Initiates | → Overweight | Get Alert | |
| 08/06/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -55.47% | $274 → $336 | Maintains | Overweight | Get Alert | |
| 07/12/2013 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -84.92% | $42 → $60 | Maintains | Overweight | Get Alert | |
| 07/01/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -63.69% | → $274 | Upgrade | Neutral → Overweight | Get Alert | |
| 04/15/2013 | LIFE | Buy Now | aTyr Pharma | — | — | $63 → $76 | Maintains | Neutral | Get Alert | |
| 02/28/2013 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $14 → $53 | Upgrade | Neutral → Overweight | Get Alert | |
| 01/28/2013 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -91.2% | $25 → $35 | Maintains | Overweight | Get Alert | |
| 12/12/2012 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -93.72% | $19 → $25 | Upgrade | Neutral → Overweight | Get Alert | |
| 11/13/2012 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -95.22% | $20 → $19 | Maintains | Neutral | Get Alert | |
| 09/24/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -81.45% | $128 → $140 | Maintains | Neutral | Get Alert | |
| 09/19/2012 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 07/25/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -83.04% | $113 → $128 | Maintains | Neutral | Get Alert | |
| 07/16/2012 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -94.97% | $17 → $20 | Maintains | Overweight | Get Alert | |
| 05/25/2012 | LIFE | Buy Now | Life Technologies | — | — | → $42 | Initiates | → Neutral | Get Alert | |
| 05/09/2012 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $12 → $16 | Maintains | Overweight | Get Alert | |
| 04/26/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -85.03% | $89 → $113 | Maintains | Neutral | Get Alert | |
| 02/13/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $754.61 | -88.21% | $81 → $89 | Maintains | Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved